Literature DB >> 12837977

Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group.

Akira Ogose1, Yasuo Yazawa, Takafumi Ueda, Tetsuo Hotta, Hiroyuki Kawashima, Hiroshi Hatano, Tetsuro Morita.   

Abstract

OBJECTIVE: The clinical features and the management of alveolar soft part sarcoma (ASPS) are not well known. The efficacy of chemotherapy for soft tissue sarcoma, including high-dose ifosfamide and cisplatin, has not been established yet. Some reports suggest ASPS may occur primarily in bone.
METHODS: We report on a series of 57 patients with ASPS over 20 years. Their ages ranged from 7 to 75 years (mean 25).
RESULTS: There were 37 females and 20 males. Thirteen lesions (23%) showed bone involvement at the primary site, and 6 of them were diagnosed as bone tumors at presentation. Thirty-seven patients had distant metastases at presentation. Tumor size, bone involvement at the primary site and the presence of metastases at presentation were prognostic indicators (p < 0.05). Marginal excision with radiotherapy or wide excision without radiotherapy achieved good local control. Chemotherapy was performed in 47 patients with different regimens. Two patients treated with intra-arterial chemotherapy regimens responded partially, but intravenous chemotherapy with high-dose ifosfamide or cisplatin failed.
CONCLUSIONS: ASPS can present primarily as a bone tumor. No advantage of chemotherapy with high-dose ifosfamide or cisplatin could be demonstrated. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837977     DOI: 10.1159/000071199

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  27 in total

1.  A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.

Authors:  Kiyoshi Hasegawa; Ryoko Ichikawa; Risa Ishii; Shuko Oe; Rina Kato; Yoichi Kobayashi; Makoto Kuroda; Yasuhiro Udagawa
Journal:  Int J Clin Oncol       Date:  2011-04-26       Impact factor: 3.402

2.  A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma.

Authors:  Y-P Liu; J Jin; W-H Wang; S-L Wang; Y-W Song; H Fang; H Ren; X-F Liu; Z-H Yu; Y-X Li
Journal:  Clin Transl Oncol       Date:  2015-06-03       Impact factor: 3.405

3.  Extended progression-free survival in two patients with alveolar soft part sarcoma exposed to tivantinib.

Authors:  John M Goldberg; Tara Gavcovich; Gaurav Saigal; Jonathan W Goldman; Lee S Rosen
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

4.  Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.

Authors:  Silvia Stacchiotti; Olivier Mir; Axel Le Cesne; Bruno Vincenzi; Alexander Fedenko; Robert G Maki; Neeta Somaiah; Shreyaskumar Patel; Mehedi Brahmi; Jean Y Blay; Kjetil Boye; Kirsten Sundby Hall; Hans Gelderblom; Nadia Hindi; Javier Martin-Broto; Hanna Kosela; Piotr Rutkowski; Antoine Italiano; Florence Duffaud; Eisuke Kobayashi; Paolo G Casali; Salvatore Provenzano; Akira Kawai
Journal:  Oncologist       Date:  2017-07-28

5.  A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.

Authors:  Ting Li; Lei Wang; Huijie Wang; Shujuan Zhang; Xiaowei Zhang; Zhiguo Luo; Chunmeng Wang
Journal:  Invest New Drugs       Date:  2016-09-08       Impact factor: 3.850

6.  Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report.

Authors:  Andrey Bychkov; Pichet Sampatanukul
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

7.  Genetic diversity in alveolar soft part sarcoma: A subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors.

Authors:  Brendan C Dickson; Catherine T-S Chung; David J Hurlbut; Paula Marrano; Mary Shago; Yun-Shao Sung; David Swanson; Lei Zhang; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-08-21       Impact factor: 5.006

Review 8.  Alveolar soft-part sarcoma in the sacrum: a case report and review of the literature.

Authors:  Patricia L Zadnik; Alp Yurter; Rosa DeLeon; Camilo A Molina; Mari L Groves; Edward McCarthy; Daniel M Sciubba
Journal:  Skeletal Radiol       Date:  2013-10-04       Impact factor: 2.199

9.  Expression of MET in alveolar soft part sarcoma.

Authors:  Hyun Jung Jun; Jeeyun Lee; Do Hyoung Lim; Joon Oh Park; Geunghwan Ahn; Sung Wook Seo; Ki-Sun Sung; Do Hoon Lim; Keon Hee Yoo; Yoon-La Choi
Journal:  Med Oncol       Date:  2009-05-27       Impact factor: 3.064

10.  Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?

Authors:  Olga Genin; Gideon Rechavi; Arnon Nagler; Ofer Ben-Itzhak; Kellie J Nazemi; Mark Pines
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.